Skip to main content
Top
Published in: Esophagus 1/2016

Open Access 01-01-2016 | Special Article

Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma

Authors: Yuji Tachimori, Soji Ozawa, Hodaka Numasaki, Hisahiro Matsubara, Masayuki Shinoda, Yasushi Toh, Harushi Udagawa, Mitsuhiro Fujishiro, Tsuneo Oyama, Takashi Uno, The Registration Committee for Esophageal Cancer of the Japan Esophageal Society

Published in: Esophagus | Issue 1/2016

Login to get access

Abstract

Background

The extent of node dissection in esophageal cancer surgery is usually estimated by the number of resected nodes, irrespective of the area of dissection. The efficacy of lymph node dissection by area was evaluated according to the location of the primary tumor.

Methods

The study group comprised the 3827 patients who underwent R0 esophagectomy with three-field lymph node dissection for squamous cell carcinoma, registered in a nationwide registry in Japan. The areas of lymph node were classified into zones according to AJCC Staging Manual. The Efficacy Index (EI) calculating the frequency and patient survival of metastases to each zone was investigated according to tumor location.

Results

The EI was high in supraclavicular and upper mediastinal zones in patients with upper esophageal tumors, highest in upper mediastinal zone followed by supraclavicular and perigastric zones in patients with middle esophageal tumors, and highest in perigastric zone followed by upper and lower mediastinal zones in patients with lower esophageal tumors. In patients with middle and lower esophageal cT1 tumors, the EIs of upper mediastinal and perigastric zones were higher than middle and lower mediastinal zones.

Conclusion

The EIs of each zone were differed by tumor location. The extent of lymph node dissection should be estimated by the dissected zones and modified by the tumor location. Supraclavicular dissection is indispensable for patients with upper esophageal tumors, and recommended for patients with middle esophageal tumors. Upper mediastinal dissection is recommended for all patients with thoracic esophageal squamous cell carcinoma, irrespective of the location.
Literature
1.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind C. UICC International Union Against Cancer. TNM classification of malignant tumors. 7th ed. Wiley-Blackwell, New York, NY 2009. Sobin LH, Gospodarowicz MK, Wittekind C. UICC International Union Against Cancer. TNM classification of malignant tumors. 7th ed. Wiley-Blackwell, New York, NY 2009.
2.
go back to reference Edge SB, Byrd DR, Compton CC, et.al. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. Springer, New York, NY 2010. Edge SB, Byrd DR, Compton CC, et.al. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. Springer, New York, NY 2010.
3.
go back to reference Ozawa S, Tachimori Y, Baba H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2004. Esophagus. 2012;9:75–98.CrossRef Ozawa S, Tachimori Y, Baba H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2004. Esophagus. 2012;9:75–98.CrossRef
4.
go back to reference Tachimori Y, Ozawa S, Fujishiro M, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2005. Esophagus. 2014;11:1–20.CrossRef Tachimori Y, Ozawa S, Fujishiro M, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2005. Esophagus. 2014;11:1–20.CrossRef
5.
go back to reference Tachimori Y, Ozawa S, Fujishiro M, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2006. Esophagus. 2014;11:21–47.CrossRef Tachimori Y, Ozawa S, Fujishiro M, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2006. Esophagus. 2014;11:21–47.CrossRef
6.
go back to reference Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2007. Esophagus. 2015;12:101–29.CrossRef Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2007. Esophagus. 2015;12:101–29.CrossRef
7.
go back to reference Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2007. Esophagus. 2015;12:130–57.CrossRef Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2007. Esophagus. 2015;12:130–57.CrossRef
8.
go back to reference Siewert JR, Stein HJ. Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82. Siewert JR, Stein HJ. Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82.
9.
go back to reference Kato H, Watanabe H, Tachimori Y, et al. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg. 1991;51:931–5.PubMedCrossRef Kato H, Watanabe H, Tachimori Y, et al. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg. 1991;51:931–5.PubMedCrossRef
11.
go back to reference Sobin LH, Wittekind C. UICC International Union Against Cancer. TNM classification of malignant tumors. 6th ed. Wiley-Liss, New York, NY 2002. Sobin LH, Wittekind C. UICC International Union Against Cancer. TNM classification of malignant tumors. 6th ed. Wiley-Liss, New York, NY 2002.
12.
go back to reference Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 10th edition: part I. Esophagus. 2009;6:1–25.CrossRef Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 10th edition: part I. Esophagus. 2009;6:1–25.CrossRef
13.
go back to reference Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.PubMedCrossRef Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.PubMedCrossRef
14.
go back to reference Fujita H, Aikou T, Tsurumaru M, et al. A new N category for cancer in the esophagogastric junction based on lymph node compartments. Esophagus. 2007;4:103–10.CrossRef Fujita H, Aikou T, Tsurumaru M, et al. A new N category for cancer in the esophagogastric junction based on lymph node compartments. Esophagus. 2007;4:103–10.CrossRef
15.
go back to reference Udagawa H, Ueno M, Shinohara H, et al. The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol. 2012;106:742–7.PubMedCrossRef Udagawa H, Ueno M, Shinohara H, et al. The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol. 2012;106:742–7.PubMedCrossRef
16.
go back to reference Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.PubMedCrossRef Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.PubMedCrossRef
17.
go back to reference Kang CH, Kim YT, Jeon SH, et al. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg. 2007;31:154–60.PubMedCrossRef Kang CH, Kim YT, Jeon SH, et al. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg. 2007;31:154–60.PubMedCrossRef
18.
go back to reference Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg 2007;11:1384–93; discussion 1393–4. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg 2007;11:1384–93; discussion 1393–4.
19.
go back to reference Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221–6.PubMedCrossRef Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221–6.PubMedCrossRef
20.
go back to reference Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112:1239–46.PubMedCrossRef Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112:1239–46.PubMedCrossRef
21.
go back to reference Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549–56.PubMedCrossRef Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549–56.PubMedCrossRef
22.
go back to reference Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46–50.PubMedCrossRef Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46–50.PubMedCrossRef
23.
go back to reference Ajani JA, D’Amico TA, Almhanna K, et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Cancer Netw. 2015;13:194–227. Ajani JA, D’Amico TA, Almhanna K, et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Cancer Netw. 2015;13:194–227.
24.
go back to reference Kuge K, Murakami G, Mizobuchi S, et al. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg. 2003;125:1343–9.PubMedCrossRef Kuge K, Murakami G, Mizobuchi S, et al. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg. 2003;125:1343–9.PubMedCrossRef
25.
go back to reference Tachimori Y, Nagai Y, Kanamori N, et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus. 2011;24:33–8.PubMedCrossRef Tachimori Y, Nagai Y, Kanamori N, et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus. 2011;24:33–8.PubMedCrossRef
Metadata
Title
Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma
Authors
Yuji Tachimori
Soji Ozawa
Hodaka Numasaki
Hisahiro Matsubara
Masayuki Shinoda
Yasushi Toh
Harushi Udagawa
Mitsuhiro Fujishiro
Tsuneo Oyama
Takashi Uno
The Registration Committee for Esophageal Cancer of the Japan Esophageal Society
Publication date
01-01-2016
Publisher
Springer Japan
Published in
Esophagus / Issue 1/2016
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-015-0515-3

Other articles of this Issue 1/2016

Esophagus 1/2016 Go to the issue